Ocular Therapeutix Inc Forecast, price target & analysts
Ocular Therapeutix Inc Target price 2025 - Analyst rating & recommendation
Ocular Therapeutix Inc Classifications & Recommendation:
Ocular Therapeutix Inc Price Target
| Target Price | $17.85 |
| Price | $11.84 |
| Potential |
50.76%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Ocular Therapeutix Inc 2026 .
The average Ocular Therapeutix Inc target price is $17.85.
This is
50.76%
register free of charge
$23.10
95.10%
register free of charge
$14.14
19.43%
register free of charge
|
|
| A rating was issued by 18 analysts: 17 Analysts recommend Ocular Therapeutix Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ocular Therapeutix Inc stock has an average upside potential 2026 of
50.76%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 63.72 | 56.19 |
| 9.03% | 11.82% | |
| EBITDA Margin | -263.65% | -484.89% |
| 94.05% | 83.91% | |
| Net Margin | -303.69% | -478.04% |
| 119.81% | 57.41% |
15 Analysts have issued a sales forecast Ocular Therapeutix Inc 2025 . The average Ocular Therapeutix Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Ocular Therapeutix Inc EBITDA forecast 2025. The average Ocular Therapeutix Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Ocular Therapeutix Inc Analysts have issued a net profit forecast 2025. The average Ocular Therapeutix Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.22 | -1.55 |
| 20.79% | 27.05% | |
| P/E | negative | |
| EV/Sales | 38.94 |
15 Analysts have issued a Ocular Therapeutix Inc forecast for earnings per share. The average Ocular Therapeutix Inc EPS is
This results in the following potential growth metrics and future valuations:
Ocular Therapeutix Inc...
Current Ocular Therapeutix Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Oct 02 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Oct 01 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Oct 01 2025 |
| Chardan Capital |
Locked
➜
Locked
|
Locked | Sep 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 08 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Oct 02 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Oct 01 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Oct 01 2025 |
|
Locked
Chardan Capital:
Locked
➜
Locked
|
Sep 15 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
